The Coronavirus Disease 2019 Crisis as Catalyst for Telemedicine for Chronic Neurological Disorders

This Viewpoint describes the reasons for and reality of a rapid advance towards telemedicine in neurology during the coronavirus disease 2019 pandemic.

Saved in:
Bibliographic Details
Published inArchives of neurology (Chicago) Vol. 77; no. 8; p. 927
Main Authors Bloem, Bastiaan R, Dorsey, E Ray, Okun, Michael S
Format Journal Article
LanguageEnglish
Published United States American Medical Association 01.08.2020
Subjects
Betacoronavirus
Catalysts
Chronic Disease
Coronavirus Infections - epidemiology
Coronavirus Infections - therapy
Coronaviruses
COVID-19
Humans
Nervous System Diseases - epidemiology
Nervous System Diseases - therapy
Neurological diseases
Neurological disorders
Neurology
Pandemics
Pneumonia, Viral - epidemiology
Pneumonia, Viral - therapy
SARS-CoV-2
Telemedicine
Telemedicine - methods
Telemedicine - trends
Viral diseases
Online AccessGet full text

Cover

More Information
Summary:This Viewpoint describes the reasons for and reality of a rapid advance towards telemedicine in neurology during the coronavirus disease 2019 pandemic.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ISSN:2168-6149
2168-6157
DOI:10.1001/jamaneurol.2020.1452